Swindells S, Andrade-Villanueva JF, Richmond GJ, et al. Long-acting cabotegravir + rilpivirine as maintenance therapy: ATLAS week 48 results. CROI 2019, abstract 139.
Langetermijneffectiviteit van Ad26.RSV.preF-RSV preF-eiwitvaccin
dec 2024 | Vaccinatie, Virale infecties